Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$8.32 - $15.45 $607,534 - $1.13 Million
-73,021 Reduced 28.25%
185,503 $1.62 Million
Q4 2023

Feb 02, 2024

SELL
$8.79 - $11.51 $130,294 - $170,612
-14,823 Reduced 5.42%
258,524 $2.96 Million
Q3 2023

Nov 08, 2023

BUY
$8.25 - $11.35 $438,421 - $603,161
53,142 Added 24.13%
273,347 $2.63 Million
Q2 2023

Aug 02, 2023

BUY
$10.1 - $11.6 $192,455 - $221,038
19,055 Added 9.47%
220,205 $2.34 Million
Q4 2022

Feb 01, 2023

SELL
$9.9 - $12.43 $117,453 - $147,469
-11,864 Reduced 5.57%
201,150 $2.49 Million
Q3 2022

Oct 28, 2022

BUY
$10.14 - $12.38 $137,559 - $167,947
13,566 Added 6.8%
213,014 $2.21 Million
Q2 2022

Aug 04, 2022

SELL
$11.05 - $12.72 $365,136 - $420,319
-33,044 Reduced 14.21%
199,448 $2.3 Million
Q1 2022

May 03, 2022

BUY
$10.61 - $12.88 $2.47 Million - $2.99 Million
232,492 New
232,492 $2.93 Million
Q4 2021

Jan 31, 2022

SELL
$10.86 - $13.95 $2.2 Million - $2.83 Million
-202,526 Closed
0 $0
Q3 2021

Oct 27, 2021

SELL
$11.92 - $13.92 $55,630 - $64,964
-4,667 Reduced 2.25%
202,526 $2.65 Million
Q2 2021

Jul 23, 2021

SELL
$10.16 - $13.11 $258,490 - $333,544
-25,442 Reduced 10.94%
207,193 $2.67 Million
Q1 2021

Apr 27, 2021

BUY
$9.04 - $11.86 $144,124 - $189,083
15,943 Added 7.36%
232,635 $2.6 Million
Q4 2020

Feb 03, 2021

SELL
$9.05 - $12.2 $37,720 - $50,849
-4,168 Reduced 1.89%
216,692 $2.47 Million
Q3 2020

Oct 27, 2020

BUY
$8.99 - $10.74 $441,534 - $527,484
49,114 Added 28.6%
220,860 $1.99 Million
Q2 2020

Aug 04, 2020

SELL
$9.14 - $11.97 $195,925 - $256,588
-21,436 Reduced 11.1%
171,746 $1.77 Million
Q4 2019

Jan 31, 2020

SELL
$8.22 - $14.0 $219,621 - $374,052
-26,718 Reduced 12.15%
193,182 $2.57 Million
Q3 2019

Oct 23, 2019

BUY
$8.59 - $10.96 $1.89 Million - $2.41 Million
219,900 New
219,900 $1.89 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $630M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.